These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6130975)

  • 21. [Pharmacological analysis of the serotonin- and glutamatergic mechanisms in the suppressive effect of neuroleptics on the pedal self-stimulation of the ventral tectum of the midbrain].
    Talalaenko AN; Boreĭsha IK
    Farmakol Toksikol; 1986; 49(3):40-3. PubMed ID: 2873054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.
    Richelson E
    J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nonspecific mechanisms of the action of anticholinesterase organophosphorus compounds].
    Badiugin IS; Titova NN; Khamitova RIa; Makarov NIa
    Voen Med Zh; 1979 Apr; (4):47-9. PubMed ID: 473626
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of receptors in the action of antiepileptic drugs.
    Airaksinen MM
    Acta Neurol Scand Suppl; 1983; 93():31-46. PubMed ID: 6132515
    [No Abstract]   [Full Text] [Related]  

  • 25. [Neuroleptics in geriatrics. Pharmacological criteria for a responsible choice and a correct use].
    van Wielink PS
    Tijdschr Gerontol Geriatr; 1984 Apr; 15(2):73-80. PubMed ID: 6144201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic ethanol consumption on human and animal receptor plasticity during aging.
    Govoni S; Padovani A; Magnoni MS; Battaini F; Rius RA; Picotti G; Civelli L; Mauri A; Trabucchi M
    Alcohol Drug Res; 1985-1986; 6(6):441-8. PubMed ID: 3015158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The types of central serotonin receptors, their functional role and participation in the action of psychopharmacologic agents].
    Abramets II
    Farmakol Toksikol; 1990; 53(5):70-5. PubMed ID: 1979281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The rat vas deferens as a test object for assessing the action of chemical compounds].
    Avakian OM
    Farmakol Toksikol; 1984; 47(5):104-10. PubMed ID: 6149950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotransmitter and neuroendocrine abnormalities associated with cocaine use.
    Dackis C; Gold MS
    Psychiatr Med; 1985; 3(4):461-83. PubMed ID: 2829287
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuroleptic binding to human brain receptors: relation to clinical effects.
    Richelson E
    Ann N Y Acad Sci; 1988; 537():435-42. PubMed ID: 2904784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptors and the mechanism of action of ECT.
    Lerer B; Belmaker RH
    Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
    [No Abstract]   [Full Text] [Related]  

  • 32. Receptors, neurotransmitters and drug responses.
    Snyder SH
    N Engl J Med; 1979 Mar; 300(9):465-72. PubMed ID: 32488
    [No Abstract]   [Full Text] [Related]  

  • 33. [The pharmacologist facing the neuroleptics].
    Costentin J
    Encephale; 1991 Jun; 17 Spec No 2():153-7. PubMed ID: 1677889
    [No Abstract]   [Full Text] [Related]  

  • 34. [Medicinal action and efficacy of neuroleptics].
    Suzuki H; Akimoto T; Gen K; Aoba A
    Ryoikibetsu Shokogun Shirizu; 2003; (38):169-71. PubMed ID: 12876957
    [No Abstract]   [Full Text] [Related]  

  • 35. The comparison of the influence of the central cholinergic system on the catalepsy induced by neuroleptics or opioids.
    Kmicińska M; Herman ZS
    Acta Pol Pharm; 1986; 43(2):171-5. PubMed ID: 2877543
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-induced alterations in neurotransmitter receptor binding and function.
    Enna SJ; Ferkany JW; Strong R
    Adv Biochem Psychopharmacol; 1980; 21():253-63. PubMed ID: 6246740
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological considerations for conscious sedation: clinical applications of receptor function.
    Becker DE
    Anesth Prog; 1991; 38(2):33-8. PubMed ID: 1667349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lithium ion modulation of the neuronal responses evoked by monoaminergic receptor agonists].
    Abramets II; Komissarov IV; Samoĭlovich IM
    Eksp Klin Farmakol; 1993; 56(2):9-11. PubMed ID: 8348051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABA receptor binding and endogenous inhibitors in normal human brain and Huntington's disease.
    Olsen RW; Van Ness P; Napias C; Bergman M; Tourtellotte WW
    Adv Biochem Psychopharmacol; 1980; 21():451-60. PubMed ID: 6246754
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action of the venom of the spider Argiope lobata on glutamatergic and cholinergic synapses].
    Usmanov PB; Kalikulov D; Shadyeva N; Tashmukhamedov BA
    Dokl Akad Nauk SSSR; 1983; 273(4):1017-8. PubMed ID: 6319102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.